摘要
综述免疫激活序列 (ISS)应用基础方面的研究进展。ISS- DNA不仅有望成为新一代高效低毒的免疫佐剂 ,而且在抗肿瘤、抗感染、促进造血、治疗免疫缺陷以及防治哮喘等方面均有非常乐观的应用前景。
The development on the investigation of the pharmacological applications of ISS\|DNA were reviewed. ISS\|DNA show promise as Th1\|promoting adjuvants and immunotherapeutic agents in treatment of cancers, infection, hematopoietic damage, immunosuppression, and asthma.\;
出处
《中国生物工程杂志》
CAS
CSCD
2002年第3期58-63,共6页
China Biotechnology